Baby born with rare disorder thrives after getting personalized gene editing treatment
The Brief
KJ Muldoon was diagnosed with a rare genetic disorder when he was born called severe CPS1 deficiency.
KJ is one in a million babies that are diagnosed with this illness.
Researchers and doctors used CRISPR gene editing to create a customized treatment for KJ.
A baby born with a rare and dangerous genetic disease is thriving after receiving an experimental gene editing treatment that was made just for him.
In a study published in the New England Journal of Medicine on Thursday, researchers said the baby's case is among the first to be successfully treated with a custom therapy that seeks to fix a tiny but critical error in his genetic code.
KJ Muldoon of Clifton Heights, Pennsylvania, was diagnosed with severe CPS1 deficiency shortly after being born. Within six months, a team at Children's Hospital of Philadelphia (CHOP) and Penn Medicine, as well as their partners, created a therapy specifically designed to correct KJ's faulty gene through CRISPR.
Dig deeper
People diagnosed with severe CPS1 deficiency lack an enzyme that is needed to help remove ammonia from their bodies.
This deficiency then leads to a build up of ammonia in their blood and becomes toxic. A liver transplant is another option to treat this illness.
By the numbers
About one in a million babies are diagnosed with this rare disease.
CRISPR is a gene editing tool that won its inventors the Nobel Prize in 2020.
Instead of cutting the DNA strand like the first CRISPR approaches, doctors employed a technique that flips the mutated DNA "letter" — also known as a base — to the correct type.
Known as "base editing," it reduces the risk of unintended genetic changes.
The backstory
Gene therapies, which can be extremely expensive to develop, generally target more common disorders in part for simple financial reasons: more patients mean potentially more sales, which can help pay the development costs and generate more profit.
The first CRISPR therapy approved by the U.S. Food and Drug Administration, for example, treats sickle cell disease, a painful blood disorder affecting millions worldwide.
Dr. Kiran Musunuru, a University of Pennsylvania gene editing expert who co-authored the study about KJ's treatment, said his team's work — funded in part by the National Institutes of Health — showed that creating a custom treatment doesn't have to be prohibitively expensive.
The cost was "not far off" from the $800,000-plus for an average liver transplant and related care, he said.
"As we get better and better at making these therapies and shorten the time frame even more, economies of scale will kick in and I would expect the costs to come down," Musunuru said.
Timeline
In February, KJ got his first IV infusion with the gene editing therapy, delivered through tiny fatty droplets called lipid nanoparticles that are taken up by liver cells.
After follow-up doses in March and April, KJ has been able to eat more normally and has recovered well from illnesses like colds, which can strain the body and exacerbate symptoms of CPS1. The 9 ½-month-old also takes less medication.
Considering his poor prognosis earlier, "any time we see even the smallest milestone that he's meeting – like a little wave or rolling over – that's a big moment for us," his mother said.
What's next
Despite the positive results, researchers caution that it's only been a few months since KJ began receiving this new treatment. He'll need to be under observation for years.
What they're saying
"We're still very much in the early stages of understanding what this medication may have done for KJ," Dr. Rebecca Ahrens-Nicklas, a gene therapy expert at CHOP, said. "But every day, he's showing us signs that he's growing and thriving."
The Source
Information for this article was taken from a Children's Hospital of Philadelphia news release and The Associated Press. This story was reported from Los Angeles.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Geek Tyrant
19 minutes ago
- Geek Tyrant
New Trailer for Marvel's IRONHEART Series Blends Magic and Technology — GeekTyrant
Marvel Studios has released a new trailer for it's Ironheart series, and this one reveals how Riri Williams combines magic and science to power her new armor. it also also introduces us to the hero's AI, N.A.T.A.L.I.E. This trailer offers a much better idea of what we can expect from the series, and it looks like there are going to play with some cool and interesting elements, especially with the mix of magic and technology. Hopefully, the story is strong. The synopsisi reads: 'Set after the events of Black Panther: Wakanda Forever , Marvel Television's Ironheart pits technology against magic when Riri Williams (Dominique Thorne)—a young, genius inventor determined to make her mark on the world—returns to her hometown of Chicago.' 'Her unique take on building iron suits is brilliant, but in pursuit of her ambitions, she finds herself wrapped up with the mysterious yet charming Parker Robbins aka The Hood (Anthony Ramos).' The cast of Ironheart also includes Lyric Ross, Alden Ehrenreich, Regan Aliyah, Manny Montana, Matthew Elam, and Anji White. Kevin Feige, Louis D'Esposito, Brad Winderbaum, Zoie Nagelhout, Chinaka Hodge, Ryan Coogler, Sev Ohanian, and Zinzi Coogler all serve as executive producers on Ironheart , while Chinaka Hodge is the head writer. Episodes are directed by Sam Bailey and Angela Barnes. The first three episodes of Ironheart will all be released together. They will hit Disney+ on June 24, 2025. There are a total of six epsiodem but it's unclear if the final three episodes, will also be released together or if they will come out on a weekly basis.
Associated Press
an hour ago
- Associated Press
Georgia's experience raises red flags for Medicaid work requirement moving through Congress
ATLANTA (AP) — Georgia's experiment with a work requirement for Medicaid offers a test of a similar mandate Republicans in Congress want to implement nationally, and advocates say the results so far should serve as a warning. Just days shy of its two-year anniversary, the Georgia Medicaid program is providing health coverage to about 7,500 low-income residents, up from 4,300 in the first year, but far fewer than the estimated 240,000 people who could qualify. The state had predicted at least 25,000 enrollees in the first year and nearly 50,000 in the second year. Applicants and beneficiaries have faced technical glitches and found it nearly impossible at times to reach staff for help, despite more than $50 million in federal and state spending on computer software and administration. The program, dubbed Georgia Pathways, had a backlog of more than 16,000 applications 14 months after its July 2023 launch, according to a renewal application Georgia submitted to the Trump administration in April. 'The data on the Pathways program speaks for itself,' said Laura Colbert, executive director of Georgians for a Healthy Future, an advocacy group that has called for a broader expansion of Medicaid without work requirements. 'There are just so many hurdles at every step of the way that it's just a really difficult program for people to enroll in and then to stay enrolled in too.' Georgia's rules A tax and spending bill backed by President Donald Trump and Republican lawmakers that passed the U.S. House in May would require many able-bodied Medicaid enrollees under 65 to show that they work, volunteer or go to school. The bill is now in the Senate, where Republicans want significant changes. Pathways requires beneficiaries to perform 80 hours a month of work, volunteer activity, schooling or vocational rehabilitation. It's the only Medicaid program in the nation with a work requirement. But Georgia recently stopped checking each month whether beneficiaries were meeting the mandate. Colbert and other advocates view that as evidence that state staff was overburdened with reviewing proof-of-work documents. Fiona Roberts, a spokeswoman for the state Department of Community Health, said Gov. Brian Kemp has mandated that state agencies 'continually seek ways to make government more efficient and accessible.' Georgia's governor defends Pathways The governor's office defended the enrollment numbers. Kemp spokesman Garrison Douglas said the early projections for Pathways were made in 2019, when the state had a much larger pool of uninsured residents who could qualify for the program. In a statement, Douglas credited the Republican governor with bringing that number down significantly through 'historic job growth,' and said the decline in uninsured residents proved 'the governor's plan to address our healthcare needs is working.' For BeShea Terry, Pathways was a 'godsend.' After going without insurance for more than a year, Terry, 51, said Pathways allowed her to get a mammogram and other screening tests. Terry touts Pathways in a video on the program's website. But in a phone interview with The Associated Press, she said she also experienced problems. Numerous times, she received erroneous messages that she hadn't uploaded proof of her work hours. Then in December, her coverage was abruptly canceled — a mistake that took months of calls to a caseworker and visits to a state office to resolve, she said. 'It's a process,' she said. 'Keep continuing to call because your health is very important.' Health advocates say many low-income Americans may not have the time or resources. They are often struggling with food and housing needs. They are also more likely to have limited access to the internet and work informal jobs that don't produce pay stubs. Republican lawmakers have promoted work requirements as a way to boost employment, but most Medicaid recipients already work, and the vast majority who don't are in school, caring for someone, or sick or disabled. Kemp's administration has defended Pathways as a way to transition people to private health care. At least 1,000 people have left the program and obtained private insurance because their income increased, according to the governor's office. After a slow start, advertising and outreach efforts for Pathways have picked up over the last year. At a job fair in Atlanta on Thursday, staff handed out information about the program at a table with mints, hand sanitizer and other swag with the Pathways' logo. A wheel that people could spin for a prize sat on one end. Since Pathways imposed the work requirement only on newly eligible state residents, no one lost coverage. The Arkansas experiment That's a contrast with Arkansas, where 18,000 people were pushed off Medicaid within the first seven months of a 2018 work mandate that applied to some existing beneficiaries. A federal judge later blocked the requirement. The bill that passed the U.S. House would likely cause an estimated 5.2 million people to lose health coverage, according to an analysis from the nonpartisan Congressional Budget Office released Wednesday. Arkansas Republican Gov. Sarah Huckabee Sanders has proposed reviving the work mandate but without requiring people to regularly report employment hours. Instead, the state would rely on existing data to determine enrollees who were not meeting goals for employment and other markers and refer those people to coaches before any decision to suspend them. Arkansas is among at least 10 states pursuing work requirements for their Medicaid programs separate from the effort in Congress. Republican state Sen. Missy Irvin said Arkansas' new initiative aims to understand who the beneficiaries are and what challenges they face. 'We want you to be able to take care of yourself and your family, your loved ones and everybody else,' Irvin said. 'How can we help you? Being a successful individual is a healthy individual.' ___ Associated Press writers Jonathan Mattise in Nashville, Tennessee, Andrew DeMillo in Little Rock, Arkansas, and Geoff Mulvihill in Philadelphia contributed to this report.
Forbes
an hour ago
- Forbes
Health Insurers Call Out Trump On Promise To Not Cut Seniors' Medicare
The nation's health insurance companies say legislation wending its way through the Republican-controlled Congress would break a promise by Donald Trump and the GOP not to cut Medicare benefits to seniors. It's the latest part of the healthcare industry to fight back against proposed federal cuts in healthcare benefits to millions of Americans. Already, physicians led by the American Medical Association have launched an ad campaign targeting U.S. Senators in an effort to thwart the budget legislation. Legislation known as the 'One Big Beautiful Bill Act' that narrowly passed the Republican-controlled U.S. House of Representatives two weeks ago would reduce federal Medicaid spending by $793 billion and increase the number of uninsured by 7.8 million, a KFF analysis shows. But the powerful lobby, America's Health Insurance Plans (AHIP) said Medicare, too, would be cut and raise costs on millions of seniors. AHIP's members include some of the nation's largest health insurers, including Elevance Health, Humana, CVS Health's Aetna and an array of Blue Cross and Blue Shield plans. These health insurers, including UnitedHealth Group's UnitedHealthcare, provide health benefits to more than half of the nation's eligible seniors through privatized coverage known as Medicare Advantage. The plans contract with the federal government to provide traditional coverage available in traditional Medicare plus extra benefits and services to seniors, such as disease management and nurse help hotlines with some also offering vision, dental care and wellness programs. 'The President and Congressional leaders made a clear promise to seniors that there would be no cuts to Medicare as part of the budget reconciliation legislation," AHIP President and CEO Mike Tuffin said Monday. 'Last-minute attempts to cut Medicare Advantage to fund other priorities would directly undermine that promise and lead to higher costs and reductions in benefits for more than 34 million seniors,' Tuffin said. "We oppose cuts to Medicare Advantage, including the No UPCODE Act, and urge Congress to keep the promise to America's seniors.' Any loss in health plan members covered by Medicare Advantage would be an added blow to health insurers. They need large numbers of subscribers paying premiums to cover their costs. Many of these same health insurers have been hit hard by rising costs from an influx of seniors purchasing Medicare Advantage.
